We further adopt our own results validated that overexpression of KPNA2 and worse probabilities of survival in ovarian carcinoma, which determined that KPNA2 mRNA expression may be an independent prognostic biomarker in ovarian carcinoma patients. The gene discussed is KPNA2; the disease is ovarian carcinoma.